DE69618630D1 - Methode zur in vitro-bestimmung der bioaktivität von erythropoietin - Google Patents

Methode zur in vitro-bestimmung der bioaktivität von erythropoietin

Info

Publication number
DE69618630D1
DE69618630D1 DE69618630T DE69618630T DE69618630D1 DE 69618630 D1 DE69618630 D1 DE 69618630D1 DE 69618630 T DE69618630 T DE 69618630T DE 69618630 T DE69618630 T DE 69618630T DE 69618630 D1 DE69618630 D1 DE 69618630D1
Authority
DE
Germany
Prior art keywords
epo
sample
vitro
cells
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69618630T
Other languages
English (en)
Other versions
DE69618630T2 (de
Inventor
J Lisi
K Glenn
Chi-Kwong So
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE69618630D1 publication Critical patent/DE69618630D1/de
Publication of DE69618630T2 publication Critical patent/DE69618630T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/746—Erythropoetin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69618630T 1996-09-20 1996-09-20 Methode zur in vitro-bestimmung der bioaktivität von erythropoietin Expired - Lifetime DE69618630T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/015049 WO1998012558A1 (en) 1996-09-20 1996-09-20 Methods for in vitro determination of erythropoietin bioactivity

Publications (2)

Publication Number Publication Date
DE69618630D1 true DE69618630D1 (de) 2002-02-21
DE69618630T2 DE69618630T2 (de) 2002-05-08

Family

ID=22255824

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618630T Expired - Lifetime DE69618630T2 (de) 1996-09-20 1996-09-20 Methode zur in vitro-bestimmung der bioaktivität von erythropoietin

Country Status (13)

Country Link
EP (1) EP0935752B1 (de)
JP (1) JP3764487B2 (de)
KR (1) KR100295506B1 (de)
AT (1) ATE209354T1 (de)
AU (1) AU715237B2 (de)
CA (1) CA2265989C (de)
DE (1) DE69618630T2 (de)
DK (1) DK0935752T3 (de)
ES (1) ES2168509T3 (de)
IL (1) IL129028A0 (de)
NO (1) NO321047B1 (de)
PT (1) PT935752E (de)
WO (1) WO1998012558A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73544A (en) * 1984-11-19 1988-11-15 Yissum Res Dev Co In vitro bioassay of erythropoietin in the absence of serum involving dna synthesis by erythroid precursors
AU4104889A (en) * 1988-09-07 1990-03-15 Bioclones (Pty) Ltd Purification of erythropoietin
JP2750600B2 (ja) * 1989-02-17 1998-05-13 雪印乳業株式会社 エリスロポエチンの生物活性測定方法
WO1992006116A1 (en) * 1990-09-28 1992-04-16 Ortho Pharmaceutical Corporation Hybrid growth factors

Also Published As

Publication number Publication date
JP3764487B2 (ja) 2006-04-05
NO991338D0 (no) 1999-03-19
EP0935752B1 (de) 2001-11-21
PT935752E (pt) 2002-03-28
CA2265989A1 (en) 1998-03-26
CA2265989C (en) 2010-11-02
DE69618630T2 (de) 2002-05-08
EP0935752A1 (de) 1999-08-18
AU7162696A (en) 1998-04-14
DK0935752T3 (da) 2002-05-21
ATE209354T1 (de) 2001-12-15
WO1998012558A1 (en) 1998-03-26
NO321047B1 (no) 2006-03-06
NO991338L (no) 1999-03-19
KR100295506B1 (ko) 2001-08-07
ES2168509T3 (es) 2002-06-16
IL129028A0 (en) 2000-02-17
KR20000048492A (ko) 2000-07-25
JP2001500736A (ja) 2001-01-23
AU715237B2 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
CA2244659A1 (en) Biological reactor for the cultivation of cells
DK0461166T4 (da) Fremgangsmåde til styring og/eller overvågning af biologiske processer
ATE115411T1 (de) Antikörper gegen eine zusammensetzung mit mediatoraktivität und seine verwendung in einer pharmazeutischen zusammensetzung.
DE69432540D1 (de) Verfahren zur Herstellung von Nucleinsäuren aus einer biologischen Probe bei niedrigem pH und unter Verwendung einer Säureprotease
PT783693E (pt) Modelos in vitro da funcao e da disfuncao do snc
ATE243532T1 (de) Verfahren zur bewertung von chemotherapeutischen mitteln in vivo
SE9403833D0 (sv) Analysförfarande och kit
DE69026024D1 (de) Künstlicher Träger zur Immobilisierung von biologischen Proteinen und Verfahren zu seiner Herstellung
DE69833660D1 (de) Nukleinsäuresonden zur detektion von candida-spezies
ATE373083T1 (de) Methode und zusammensetzungen zur identifizierung von morphogen-analogen
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
DE69704279D1 (de) Verfahren zur detektion und/oder quantitativen bestimmung von einem gliotoxischen faktor
ATE222122T1 (de) Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen
ATE209354T1 (de) Methode zur in vitro-bestimmung der bioaktivität von erythropoietin
DE60022879D1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
ATE445021T1 (de) Reduktion von kreuzkontaminationen bei nukleinsäureamplifikationen
Geering The influence of the fungicide merthiolate on insect esterases in disc electrophoresis
DE60025036D1 (de) Verfahren zur züchtung von haftenden tierischen zellen
BR9612790A (pt) Métodos para determinação in vitro de bioatividade de eritropoietina.
DE69918132D1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
Clark Red cell lactic acid dehydrogenase in the family Macropodidae
PT97820A (pt) Processo de obtencao de proteina map2-quinases, de microorganismos e linhas de celulas compreendendo moleculas recombinantes de map2-quinase e de detencao da presenca de actividade de factores celulares
DE69807410D1 (de) Auf Enzym-gegründetes Assay zur Bestimmung der Wirkung von exogenen und endogenen Faktoren auf Zellenergie-Bildung
ATE121777T1 (de) Träger für biologisch wirksame moleküle oder biologisch wirksamer träger, verfahren zu seiner herstellung und seine biologische verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN